发明名称 3-SUBSTITUTED OXINDOLE BETA-3 AGONISTS
摘要 The present invention relates to a beta 3 adrenergic receptor agonist of formula I: (I);or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
申请公布号 WO03016276(A2) 申请公布日期 2003.02.27
申请号 WO2002US21316 申请日期 2002.08.06
申请人 ELI LILLY AND COMPANY;BASTIAN, JOLIE, ANNE;FINLEY, DON, RICHARD;HE, JOHN, XIAOQIANG;JESUDASON, CYNTHIA, DARSHINI;RATZ, ANDREW, MICHAEL;ROCCO, VINCENT, PATRICK;RUEHTER, GERD;SALL, DANIEL, JON;SCHOTTEN, THEO;SPINAZZE, PATRICK, GIANPIETRO;STEVENS, FREDDIE, CRAIG;TRANKLE, WILLIAM, GEORGE;WERNER, JOHN, ARNOLD 发明人 BASTIAN, JOLIE, ANNE;FINLEY, DON, RICHARD;HE, JOHN, XIAOQIANG;JESUDASON, CYNTHIA, DARSHINI;RATZ, ANDREW, MICHAEL;ROCCO, VINCENT, PATRICK;RUEHTER, GERD;SALL, DANIEL, JON;SCHOTTEN, THEO;SPINAZZE, PATRICK, GIANPIETRO;STEVENS, FREDDIE, CRAIG;TRANKLE, WILLIAM, GEORGE;WERNER, JOHN, ARNOLD
分类号 A01N41/12;A61K31/4045;A61K31/4178;A61K31/4196;A61K31/427;A61K31/4439;A61K31/497;A61P3/04;A61P3/10;C07D209/34;C07D209/96;C07D401/14;C07D403/12;C07D403/14;C07D405/12;C07D409/12;C07D409/14;C07D417/14;C07D521/00 主分类号 A01N41/12
代理机构 代理人
主权项
地址